Thromb Haemost 2003; 89(03): 583-589
DOI: 10.1055/s-0037-1613390
New Technologies and Diagnostic Tools
Schattauer GmbH

2MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves

Stefan Pfaffenberger
1   Department of Internal Medicine II, University of Vienna, Austria
,
Branka Devcic-Kuhar
2   Institute of General Physics, Vienna University of Technology, Austria
,
Karem El-Rabadi
1   Department of Internal Medicine II, University of Vienna, Austria
,
Martin Gröschl
2   Institute of General Physics, Vienna University of Technology, Austria
,
Walter S. Speidl
1   Department of Internal Medicine II, University of Vienna, Austria
,
Thomas W. Weiss
1   Department of Internal Medicine II, University of Vienna, Austria
,
Kurt Huber
1   Department of Internal Medicine II, University of Vienna, Austria
,
Ewald Benes
2   Institute of General Physics, Vienna University of Technology, Austria
,
Gerald Maurer
1   Department of Internal Medicine II, University of Vienna, Austria
,
Johann Wojta
1   Department of Internal Medicine II, University of Vienna, Austria
,
Michael Gottsauner-Wolf
1   Department of Internal Medicine II, University of Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received 18 September 2002

Accepted after revision after revision 16 December 2002

Publication Date:
09 December 2017 (online)

Summary

In addition to fibrinolytic enzymes, ultrasound has the potential to enhance thrombolysis. High frequency ultrasound has the advantage that a combination of diagnostic and therapeutic ultrasound with only one device is possible. Therefore, we investigated the optimal high frequency (2 MHz) ultrasound field characteristics and application mode in vitro. Continuous ultrasound significantly enhanced rt-PA mediated thrombolysis: in a travelling wave field thrombolysis was augmented by 49.0 ± 14.7% and in a standing wave field by 34.8 ± 7.3%. In an intermittent application mode (1Hz, 10Hz, 100Hz, 1kHz) most efficient results were obtained for both wave fields using 1 Hz (46.4 ± 10.7% and 39.1 ± 6.6%, respectively). Referring to a possible in vivo application our in vitro data suggests that an intermittent application of a 2 MHz high frequency ultrasound using a travelling wave field would be the most potent application for lysing blood clots.

 
  • References

  • 1 Lincoff AM, Topol EJ. Illusion of reperfusion – does anyone achieve optimal reperfusion during acute myocardial infarction?. Circulation 1993; 87: 1792-805.
  • 2 Huber K. Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents. Wien Klin Wochenschr 2000; 112: 742-8.
  • 3 Sobbe A, Stumpff U, Trubestein G, Figge H, Kozuschek W. Thrombolysis by ultrasound. Klin Wochenschr 1974; 52: 1117-21.
  • 4 Rosenschein U, Roth A, Rassin T, Basan S, Laniado S, Miller I H. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial). Results of the feasibility phase. Circulation 1997; 95: 1411-6.
  • 5 Atar S, Luo H, Nagai T, Siegel RJ. Ultrasonic thrombolysis: catheter-delivered and transcutaneous applications. Eur J Ultrasound 1999; 9: 39-54.
  • 6 Luo H, Birnbaum Y, Fishbein MC, Peterson TM, Nagai T, Nishioka T. et al Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res 1998; 89: 171-7.
  • 7 Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation 1998; 98: 1030-5.
  • 8 Luo H, Nishioka T, Fishbein MC, Cercek B, Forrester JS, Kim CJ. et al Transcutaneous ultrasound augments lysis of arterial thrombi in vivo . Circulation 1996; 94: 775-8.
  • 9 Birnbaum Y, Luo H, Nagai T, Fishbein MC, Peterson TM, Li S. et al Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation 1998; 97: 130-4.
  • 10 Suchkova VN, Baggs RB, Francis CW. Effect of 40-kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion. Circulation 2000; 101: 2296-301.
  • 11 Siegel RJ, Atar S, Fishbein MC, Brasch AV, Peterson TM, Nagai T. et al Noninvasive, transthoracic, low-frequency ultrasound augments thrombolysis in a canine model of acute myocardial infarction. Circulation 2000; 101: 2026-9.
  • 12 Siegel RJ, Atar S, Fishbein MC, Brasch AV, Peterson TM, Nagai T. et al Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries. Echocardiography 2001; 18: 247-57.
  • 13 Birnbaum Y, Luo H, Atar S, Fishbein MC, Brasch AV, Nagai T. et al Noninvasive transthoracic low frequency ultrasound augments thrombolysis in a canine model of acute myocardial infarction – evaluation of the extent of ST-segment resolution. J Thromb Thrombolysis 2001; 11: 229-34.
  • 14 Everbach EC, Francis CW. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med Biol 2000; 26: 1153-60.
  • 15 Sakharov DV, Hekkenberg RT, Rijken DC. Acceleration of fibrinolysis by high-frequency ultrasound: the contribution of acoustic streaming and temperature rise. Thromb Res 2000; 100: 333-40.
  • 16 Mizushige K, Kondo I, Ohmori K, Hirao K, Matsuo H. Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: dependence on microbubble structure. Ultrasound Med Biol 1999; 25: 1431-7.
  • 17 Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS. et al High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 2000; 31: 610-4.
  • 18 Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke 2002; 33: 626-8.
  • 19 Groeschl M. BW, Handl B., Doblhoff-Dier O., Gaida T, Schmatz C. Ultrasonic separation of suspended particles – Part III: Application in biotechnology. Acoustica – acta acoustica 1998; 84: 815-822.
  • 20 Rijken DC, Sakharov DV. Molecular transport during fibrin clot lysis. Fibrinolysis & Proteolysis 2000; 14: 65-214.
  • 21 Chater BV, Williams AR. Platelet aggregation induced in vitro by therapeutic ultrasound. Thromb Haemost 1977; 38: 640-51.
  • 22 Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis. Circulation 1992; 86: 1257-64.
  • 23 Harpaz D, Chen X, Francis CW, Meltzer RS. Ultrasound accelerates urokinase-induced thrombolysis and reperfusion. Am Heart J 1994; 127: 1211-9.
  • 24 Blinc A, Francis CW, Trudnowski JL, Carstensen EL. Characterization of ultrasound-potentiated fibrinolysis in vitro . Blood 1993; 81: 2636-43.
  • 25 Kandarpa K, Drinker PA, Singer SJ, Caramore D. Forceful pulsatile local infusion of enzyme accelerates thrombolysis: in vivo evaluation of a new delivery system. Radiology 1988; 168: 739-44.
  • 26 Dyson M, Pond JB, Woodward B, Broadbent J. The production of blood cell stasis and endothelial damage in the blood vessels of chick embryos treated with ultrasound in a stationary wave field. Ultrasound Med Biol 1974; 1: 133-48.
  • 27 Lehmann JF, DeLateur BJ, Stonebridge JB, Warren CG. Therapeutic temperature distribution produced by ultrasound as modified by dosage and volume of tissue exposed. Archives of pysical medicine and rehabilitation 1967; 48: 662-6.
  • 28 Lehmann JF, DeLateur BJ, Stonebridge JB, Warren CG. Heating produced by ultrasound in bone and soft tissue. Archives of pysical medicine and rehabilitation 1967; 48: 397-401.
  • 29 Nilsson AM, Odselius R, Roijer A, Olsson SB. Pro-and antifibrinolytic effects of ultrasound on streptokinase-induced thrombolysis. Ultrasound Med Biol 1995; 21: 833-40.
  • 30 Mavromatis BH, Kessler CM. D-dimer testing: the role of the clinical laboratory in the diagnosis of pulmonary embolism. J Clin Pathol 2001; 54: 664-8.
  • 31 Kimura M, Iijima S, Kobayashi K, Furuhata H. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasonic irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull 1994; 17: 126-30.